# Super-voltage PRF of Stellate Ganglion Versus Super-voltage PRF of T2 T3 Sympathetic Ganglia in Managing PMPS.

> **NCT07675096** · NA · NOT_YET_RECRUITING · sponsor: **National Cancer Institute, Egypt** · enrollment: 75 (estimated)

## Conditions studied

- Post Mastectomy Pain Syndrome
- Chronic Pain Following Surgical Procedure for Cancer

## Interventions

- **PROCEDURE:** Group S : Stellate Ganglion supervoltage pulsed radiofrequency
- **PROCEDURE:** Group T : T2-T3 chains supervoltage pulsed radiofrequency.

## Key facts

- **NCT ID:** NCT07675096
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-08-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675096, "Super-voltage PRF of Stellate Ganglion Versus Super-voltage PRF of T2 T3 Sympathetic Ganglia in Managing PMPS.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*